Bing Cheng
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 2
- CRISPR and Genetic Engineering 1
- Genomics and Phylogenetic Studies 1
- RNA modifications and cancer 1
- Oncology 3
- Cancer Cells and Metastasis 2
- Co-authors
- Wenyu Wang (6 shared papers)Qiang Yu (4 shared papers)Zhitong Niu (2 shared papers)Yufeng Chen (2 shared papers)Qian Xiao (2 shared papers)Xiaojian Wu (2 shared papers)Yuwen Wang (1 shared paper)Shujun Zhang (1 shared paper)
In The Last Decade
Bing Cheng
10 papers receiving 368 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 69
- Oncology 104
- Molecular Biology 219
- Immunology 45
- Ophthalmology 10
Countries citing papers authored by Bing Cheng
This map shows the geographic impact of Bing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Cheng more than expected).
Fields of papers citing papers by Bing Cheng
This network shows the impact of papers produced by Bing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Cheng. The network helps show where Bing Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 94 | |
| 2 | 2021 | 77 | |
| 3 | 2016 | 55 | |
| 4 | 2019 | 31 | |
| 5 | 2023 | 29 | |
| 6 | 2015 | 28 | |
| 7 | 2021 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 15 | |
| 10 | 2025 | 8 |
About Bing Cheng
Bing Cheng is a scholar working on Molecular Biology, Oncology, Cancer Research, Ophthalmology and Hematology, having authored 10 papers that have together received 374 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers), CRISPR and Genetic Engineering (1 paper), Multiple Myeloma Research and Treatments (1 paper), Genomics and Phylogenetic Studies (1 paper), RNA modifications and cancer (1 paper), Cancer Genomics and Diagnostics (1 paper) and Chromosomal and Genetic Variations (1 paper). The work is most often cited by research in Cancer Research (69 citations), Oncology (104 citations), Molecular Biology (219 citations), Immunology (45 citations) and Ophthalmology (10 citations). Bing Cheng has collaborated with scholars based in China, Singapore and Taiwan. Frequent co-authors include Wenyu Wang, Qiang Yu, Zhitong Niu, Yufeng Chen, Qian Xiao, Xiaojian Wu, Yuwen Wang, Shujun Zhang, Jie Yao and Xiaoming Huang. Their work appears in journals such as Disease Models & Mechanisms, Biomedical Reports, Aging, Journal of Biomedical Science and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.